Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CKAP4 | Human | (+)-schisandrin B | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKAP4 mRNA] | CTD | PMID:31150632 | CKAP4 | Human | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of CKAP4 protein | CTD | PMID:31195006 | CKAP4 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP4 mRNA | CTD | PMID:36331819 | CKAP4 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CKAP4 mRNA | CTD | PMID:22206623 | CKAP4 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CKAP4 mRNA | CTD | PMID:30723492 | CKAP4 | Human | 17beta-estradiol | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Estradiol results in increased expression of CKAP4 mRNA | CTD | PMID:19484750 | CKAP4 | Human | 17beta-estradiol | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of CKAP4 mRNA | CTD | PMID:32145629 | CKAP4 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of CKAP4 mRNA | CTD | PMID:30165855 | CKAP4 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP4 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ckap4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CKAP4 mRNA | CTD | PMID:21570461 | CKAP4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CKAP4 mRNA | CTD | PMID:33387578 | CKAP4 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CKAP4 mRNA | CTD | PMID:34747641 | CKAP4 | Human | 2,4-dinitrotoluene | affects expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | 2 and 4-dinitrotoluene affects the expression of CKAP4 mRNA | CTD | PMID:21346803 | CKAP4 | Human | 3-chloropropane-1,2-diol | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of CKAP4 protein | CTD | PMID:34915118 | CKAP4 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CKAP4 mRNA | CTD | PMID:28628672 | CKAP4 | Human | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CKAP4 mRNA | CTD | PMID:28628672 | CKAP4 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Ckap4 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CKAP4 gene | CTD | PMID:31683443 | CKAP4 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CKAP4 protein | CTD | PMID:34186270 | CKAP4 | Human | 4-amino-2,6-dinitrotoluene | affects expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of CKAP4 mRNA | CTD | PMID:21346803 | CKAP4 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Fenretinide results in increased expression of CKAP4 mRNA | CTD | PMID:28973697 | CKAP4 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of CKAP4 mRNA | CTD | PMID:24780913 and PMID:30047161 | CKAP4 | Human | acetamide | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CKAP4 mRNA | CTD | PMID:31881176 | CKAP4 | Human | acrylamide | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of CKAP4 mRNA | CTD | PMID:28959563 | CKAP4 | Human | acrylamide | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Acrylamide results in increased expression of CKAP4 mRNA | CTD | PMID:30807115 | CKAP4 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of CKAP4 mRNA | CTD | PMID:27153756 | CKAP4 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of CKAP4 intron | CTD | PMID:30157460 | CKAP4 | Human | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CKAP4 mRNA | CTD | PMID:33167477 | CKAP4 | Human | amitrole | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of CKAP4 mRNA | CTD | PMID:30047161 | CKAP4 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CKAP4 mRNA | CTD | PMID:33212167 | CKAP4 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of CKAP4 gene | CTD | PMID:25304211 | CKAP4 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of CKAP4 gene | CTD | PMID:25304211 | CKAP4 | Human | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of CKAP4 mRNA | CTD | PMID:12852829 | CKAP4 | Human | atrazine | affects methylation | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of CKAP4 gene | CTD | PMID:35440735 | CKAP4 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CKAP4 promoter | CTD | PMID:27901495 | CKAP4 | Human | benzo[a]pyrene | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CKAP4 mRNA | CTD | PMID:32417428 | CKAP4 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:19150397 | CKAP4 | Human | benzoates | increases expression | EXP | | 6480464 | Benzoates analog results in increased expression of CKAP4 mRNA | CTD | PMID:29472718 | CKAP4 | Human | bisphenol A | affects expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CKAP4 mRNA | CTD | PMID:25181051 | CKAP4 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CKAP4 protein | CTD | PMID:34186270 | CKAP4 | Human | bisphenol A | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CKAP4 mRNA | CTD | PMID:32145629 | CKAP4 | Human | bisphenol A | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CKAP4 mRNA | CTD | PMID:30816183 | CKAP4 | Human | Bisphenol B | increases expression | EXP | | 6480464 | bisphenol B results in increased expression of CKAP4 protein | CTD | PMID:34186270 | CKAP4 | Human | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of CKAP4 protein | CTD | PMID:34186270 | CKAP4 | Human | cadmium dichloride | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CKAP4 mRNA | CTD | PMID:25993096 | CKAP4 | Human | carbon nanotube | affects expression | ISO | Ckap4 (Mus musculus) | 6480464 | Nanotubes and Carbon affects the expression of CKAP4 protein | CTD | PMID:21135415 | CKAP4 | Human | carbon nanotube | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CKAP4 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CKAP4 gene] | CTD | PMID:28238834 | CKAP4 | Human | chloropicrin | decreases expression | EXP | | 6480464 | chloropicrin results in decreased expression of CKAP4 mRNA | CTD | PMID:26352163 | CKAP4 | Human | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of CKAP4 protein | CTD | PMID:34122009 | CKAP4 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of CKAP4 mRNA | CTD | PMID:19320972 | CKAP4 | Human | copper atom | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CKAP4 mRNA | CTD | PMID:15467011 | CKAP4 | Human | copper atom | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CKAP4 mRNA | CTD | PMID:24690739 | CKAP4 | Human | copper(0) | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CKAP4 mRNA | CTD | PMID:15467011 | CKAP4 | Human | copper(0) | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CKAP4 mRNA | CTD | PMID:24690739 | CKAP4 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of CKAP4 protein | CTD | PMID:35688186 | CKAP4 | Human | coumestrol | decreases expression | EXP | | 6480464 | Coumestrol results in decreased expression of CKAP4 mRNA | CTD | PMID:19167446 | CKAP4 | Human | cyclosporin A | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Cyclosporine results in increased expression of CKAP4 mRNA | CTD | PMID:21865292 | CKAP4 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CKAP4 mRNA | CTD | PMID:20106945 more ... | CKAP4 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CKAP4 mRNA | CTD | PMID:22147139 | CKAP4 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CKAP4 mRNA | CTD | PMID:28628672 | CKAP4 | Human | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of CKAP4 mRNA | CTD | PMID:12852829 | CKAP4 | Human | disulfiram | multiple interactions | EXP | | 6480464 | [Disulfiram binds to Copper] which results in increased expression of CKAP4 mRNA | CTD | PMID:24690739 | CKAP4 | Human | dopamine | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Dopamine results in increased expression of CKAP4 mRNA | CTD | PMID:21983523 | CKAP4 | Human | doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of CKAP4 protein | CTD | PMID:29385562 | CKAP4 | Human | endosulfan | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of CKAP4 mRNA | CTD | PMID:29391264 and PMID:31464424 | CKAP4 | Human | fenoldopam | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Fenoldopam results in increased expression of CKAP4 mRNA | CTD | PMID:21983523 | CKAP4 | Human | fenvalerate | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of CKAP4 mRNA | CTD | PMID:30307764 | CKAP4 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of CKAP4 mRNA | CTD | PMID:23649840 | CKAP4 | Human | FR900359 | affects phosphorylation | EXP | | 6480464 | FR900359 affects the phosphorylation of CKAP4 protein | CTD | PMID:37730182 | CKAP4 | Human | furan | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | furan results in increased expression of CKAP4 mRNA | CTD | PMID:25539665 and PMID:27387713 | CKAP4 | Human | furan | decreases methylation | ISO | Ckap4 (Rattus norvegicus) | 6480464 | furan results in decreased methylation of CKAP4 gene | CTD | PMID:27387713 | CKAP4 | Human | gentamycin | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CKAP4 mRNA | CTD | PMID:33387578 | CKAP4 | Human | indole-3-methanol | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CKAP4 mRNA | CTD | PMID:22129741 | CKAP4 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CKAP4 mRNA | CTD | PMID:28628672 | CKAP4 | Human | inulin | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CKAP4 mRNA | CTD | PMID:36331819 | CKAP4 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of CKAP4 protein | CTD | PMID:32959892 | CKAP4 | Human | methapyrilene | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of CKAP4 mRNA | CTD | PMID:30467583 | CKAP4 | Human | methimazole | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of CKAP4 mRNA | CTD | PMID:30047161 | CKAP4 | Human | methotrexate | affects response to substance | EXP | | 6480464 | CKAP4 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | CKAP4 | Human | methoxychlor | increases methylation | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Methoxychlor results in increased methylation of CKAP4 gene | CTD | PMID:23303685 | CKAP4 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of CKAP4 mRNA | CTD | PMID:23649840 | CKAP4 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CKAP4 mRNA and [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CKAP4 mRNA | CTD | PMID:22129741 and PMID:28943392 | CKAP4 | Human | oxaliplatin | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CKAP4 mRNA | CTD | PMID:25729387 | CKAP4 | Human | ozone | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CKAP4 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CKAP4 mRNA | CTD | PMID:34911549 | CKAP4 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CKAP4 mRNA | CTD | PMID:21420995 | CKAP4 | Human | paracetamol | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of CKAP4 mRNA | CTD | PMID:33387578 | CKAP4 | Human | paraquat | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of CKAP4 mRNA | CTD | PMID:32680482 | CKAP4 | Human | PCB138 | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP4 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ckap4 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP4 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CKAP4 mRNA | CTD | PMID:36331819 | CKAP4 | Human | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of CKAP4 protein | CTD | PMID:22609092 | CKAP4 | Human | phenobarbital | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Phenobarbital results in increased expression of CKAP4 mRNA | CTD | PMID:30047161 | CKAP4 | Human | pirinixic acid | decreases expression | ISO | Ckap4 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CKAP4 mRNA | CTD | PMID:17426115 | CKAP4 | Human | resveratrol | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | resveratrol results in increased expression of CKAP4 mRNA | CTD | PMID:25905778 | CKAP4 | Human | rotenone | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Rotenone results in increased expression of CKAP4 mRNA | CTD | PMID:32937126 | CKAP4 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CKAP4 protein | CTD | PMID:37664457 | CKAP4 | Human | silicon dioxide | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CKAP4 mRNA | CTD | PMID:23221170 | CKAP4 | Human | sulfadimethoxine | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of CKAP4 mRNA | CTD | PMID:30047161 | CKAP4 | Human | tacrolimus hydrate | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Tacrolimus results in increased expression of CKAP4 mRNA | CTD | PMID:21865292 | CKAP4 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of CKAP4 mRNA | CTD | PMID:31758290 | CKAP4 | Human | tetrachloromethane | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CKAP4 mRNA | CTD | PMID:17484886 and PMID:31919559 | CKAP4 | Human | tetrachloromethane | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CKAP4 mRNA] | CTD | PMID:31150632 | CKAP4 | Human | tetrachloromethane | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of CKAP4 mRNA | CTD | PMID:31150632 | CKAP4 | Human | thioacetamide | increases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CKAP4 mRNA | CTD | PMID:23411599 and PMID:34492290 | CKAP4 | Human | thioacetamide | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CKAP4 mRNA | CTD | PMID:28943392 | CKAP4 | Human | titanium dioxide | increases expression | ISO | Ckap4 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CKAP4 mRNA | CTD | PMID:23557971 | CKAP4 | Human | titanium dioxide | decreases expression | ISO | Ckap4 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CKAP4 mRNA | CTD | PMID:29264374 | CKAP4 | Human | topotecan | multiple interactions | ISO | Ckap4 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CKAP4 mRNA | CTD | PMID:25729387 | CKAP4 | Human | trichloroethene | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CKAP4 mRNA | CTD | PMID:33387578 | CKAP4 | Human | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of CKAP4 mRNA | CTD | PMID:29024780 | CKAP4 | Human | tungsten | decreases expression | ISO | Ckap4 (Mus musculus) | 6480464 | Tungsten results in decreased expression of CKAP4 mRNA | CTD | PMID:30912803 | CKAP4 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of CKAP4 mRNA | CTD | PMID:28818685 | CKAP4 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CKAP4 mRNA | CTD | PMID:25979313 | CKAP4 | Human | vinclozolin | decreases expression | ISO | Ckap4 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of CKAP4 mRNA | CTD | PMID:23034163 | CKAP4 | Human | zinc atom | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of CKAP4 mRNA | CTD | PMID:22171008 | CKAP4 | Human | zinc(0) | increases expression | EXP | | 6480464 | Zinc deficiency results in increased expression of CKAP4 mRNA | CTD | PMID:22171008 | |
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
